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Summary: The levels of glycated haemoglobins and albumin were determined in 56 diabetic patients aged
between 5 and 19 years. The glycohaemoglobin levels were measured by two different methods, cation-ex-
change chromatography and a colorimetric chemical method. The glycated albumin levels were measured by a
chemical method in plasma albumin purified with Affi-gel Blue. Thejesults were compared with other indica-
tors such äs blood glucose and urinary glucose. The postprandial blood glucose levels were well correlated
with the levels of glycoproteins: glycohaemoglobin by the colunin method (r = 0.886), glycohaemoglobin by
the chemical method (r = 0.72) and glycoalbumin (r = 0.662). The urinary levels of glucose showed a weak
correlation with blood glucose levels (r = 0.214) and with glycoalbumin (r = 0.298), but no correlation with
glycohaemoglobin. Significant correlations between the changes of glycated albumin levels and glycohaemo-
globin were found (r = 0.78). The result of the comparison of the chemical method with the column method
for glycohaemoglobin determination showed a high correlation between the values (r = 0.95). There were
significant differences in glycated protein levels between normal and diabetics. There were also significant
differences in glycohaemoglobin and glycoalbumin values between fairly managed and poorly managed
groups of diabetics. Of the three parameters, glycoalbumin, glycohaemoglobin and plasma glucose, the grea-
test absolute changes were found in the levels of glycoalbumin.
Glykosyliertes Hämoglobin und glykosyliertes Albumin:
Erprobung verschiedener Methoden bei der Diabeteskontrolle
Zusammenfassung: Bei 56 diabetischen Patienten im Alter zwischen 5 und 19 Jahren wurden die Konzentra-
tionen des glykosylierten Hämoglobins und des glykosylierten Albumins ermittelt. Glykohämoglobin wurde
sowohl mittels Kationenaustauscherchromatographie als auch mit einer kolonmetrischen chemischen Metho-
de bestimmt. Da_s glykösylierte Albumin wurde nach Reinigung des Plasmaalbumins mit Affi-gel-Blue che-
misch bestimmt. Die ermittelten Werte wurden mit den Blutglucosekonzentrationen und der renalen Gluco-
seausscheidung verglichen. Die postprandialen Blutglucosekonzentrationen korrelierten gut mit den Konzen-
trationen des säulenchromatographisch bestimmten HbAi (r = 0,886), denjenigen des chemisch bestimm-
ten HbAi (r = 0,72) und denjenigen des Glykoalbumins (r = 0,662). Es fand sich eine schwache Korrelation
der Uringlucose mit der Blutglueose (r == 0,214) und dem Glykoalbumin (r = 0,298), aber keine mit HbAi.
Die Konzentrationen des glykosylierten Albumins zeigten signifikante Korrelationen mit denjenigen von
HbAi (r = 0,78). Eine starke Korrelation (r = 0,95) bestand zwischen den säulenchromatographisch und den
chemisch bestimmten HbAi-Werten. Die Konzentrationen der glykosylierten Proteine der Diabetiker unter-
schieden sich signifikant von denjenigen der normalen Probanden. Das gleiche trifft für die Unterschiede
zwischen gut und schlecht eingestellten Diabetikern zu, wobei die größte Trennschärfe mit der Bestimmung
des glykosylierten Albumins erreicht wurde.
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Introduction
In conditions involving certain periods of hypergly-
caemia, e.g. diabetes, levels of a variety of glycated
proteins are increased (1-5). The major focus of
nonenzymatic glycation in recent years has been on
haemoglobin. Clinical studies have confirmed that
the concentration of glycated haemoglobin (HbAi)
is a convenient indicator for not only the diagnosis of
diabetes, but also for the control and progress of the
disease (1—3). Several researchers have recently de-
scribed the relevance of measuring glycated serum
protein and albumin (4, 5). Glycated albumin is re-
ported to be more sensitive than glycohaemoglobin
to changes in serum glucose (6). It has been general-
ly accepted that glycated serum protein can serve äs
a short-term integrator of blood glucose homeostasis
in diabetes, and HbAi measurements äs a long-term
integrator (6—8). Various techniques have been de-
scribed for the determination of glycated proteins
such äs cation-excvhange chromatography (9—12),
isoelectric focusing (13), a colorimetric chemical
procedure (14, 15) and a radioimmunoassay (16). In
this study we investigated levels of HbAi with two
different methods, and glycated albumin levels with a
single method in the ambulatory patients from our
"Diabetic Clinic". We correlated the levels of glycat-
ed proteins with other indicators, such äs blood glu-
cose and urinary glucose.
Materials and Methods
Pat ients
180 samples from 56 insulin-dependent diabetics and 15 control
subjects analysed over a 10 month period were selected for the
study. The diabetic population included 22 boys and 34 girls with
an average age of 13.5 years; the control group comprised 6 males
and 9 females with an average age of 20 years. The diabetic
groups were divided into three groups according to the physician's
evaluation,
a fairly well controlled group (Gl),
a group with average control (G2) and
a poorly managed group (G3).
The grouping was based on the average blood glucose levels and
the renal glucose excretion.
Approximately 1-5% of total carbohydrates ingested were ex-
creted äs glucose in the urine in G l, in G2 5-10% and in G3 over
10%. Due to wide individual Variation (see minimum and maxi-
mum data in tab. 1) the difference between the groups, especially
between G l and G2, is not very distinct.
Sample collection
Heparinized blood samples were centrifuged at 1500 g for 10
minutes and plasma was separated from the cells. The cells were
washed three times with a 9 g/l NaCl solution and frozen at
-20 °C until used. A portion of plasma was deproteinized with
trichloroacetic acid within 20 minutes after venipuncture and the
supernates were used for determination of glucose concentrations
The remaining plasma was dialysed in H2O for 2 hours and used
for the mesurement of glycated albumin. 24 hour urine samples (3
x 8 hour portions) were collected prior to the withdrawal of
blood, and frozen until used.
Reagents
Prefilled cation-exchange columns were either from Bio-Rad
Labs., U.S.A. (Bio-Rex 70, 0.6 x 4 cm) or from Boehringer
Mannheim, F.R.G. (l g per column, 0.6 x 6 cm). Testcombina-
tion kit for glucose determination was also from Boehringer; Affi-
gel Blue (50—100 mesh; binding capacity, 9.5 mg/ml) was from
Bio-Rad Labs.; thiobarbituric acid and hydroxymethylfurfural
were from Sigma Chemie, F.R.G.; and other chemicals from
Merck, Darmstadt, F.R.G..
Procedures
Measurement of glucose in urine and plasma
Glucose levels in plasma and urine were measured with a hexoki-
nase method adapted to a micro-procedure in our laboratory. The
glucose levels were expressed in plasma äs mmol/1 blood and glu-
cose in urine äs g/24 h.
Determination of HbAi on a cation-exchange column '
Haemoglobin fractionation and quantitation were performed on
mini resin columns of a weakly acidic carboxylic cation-ex-
changer. Washed erythfocytes (0.1 ml) were haemolyzed in 0.5 ml
polyethyleneether (volume fractipn 0.0033). After 15 min a 0.1
ml portion was chromatographed with 10 ml 40 mmpl/I phosphate
buffer pH 6.7 at 25 °C. Results are expressed äs the ffactipn of the
total haemoglobin chromatographed. Haemoglobin was deter-
mined colorimetrically by formation of cyanomethaemoglobin
with 0.05 mmol/1 KCNO and 0.2 mol/1 K3 [Fe(CN)6].
Determination of HbAi by the chemical procedure
The assay procedure was according to the method described by
Parker et al. (15). The fructose moiety of glycated haemoglobin is
converted to 5-hydroxymethylfurfuräl by heating with oxalic acid
for 60 min in an autoclave at 125 °C (5,ul o£washed erythrocytes
in 0.1 ml 0.3 mol/1 oxalic acid). The adiduct formed by reacting 2-
thiobarbituric acid with hydroxymethylfurfural is measured pho-
tometrically. A hydroxymethylfurfural solution containing 40
/ was used äs a Standard. The results were expressed äs hy-
droxymethylfurfural formed, nmol/mg Hb.
Tab. 1. Clinical feätures and glucose concentrations in blood and
urine.
Subjects Age n
(years)
Postprandial
blood glucose
(mmol/1)
Urine glucose
(g/24 h)
Normal 1-40 15 6.2a(5.3- 6.8)b n.d.c
Diabetics
Gl 5-17 16 6.7(4.7-14,8) 12.1a( 0 - 27.1)b
G2 7-19 11 12.2(4.7-14.6) 17.4(6.5-35)
G3 9-19 29 15.2(7.1-25.8) 62.9 (12.9-128)
Total 5-19 56 12.1(4.7-25.8) 2 8 . 9 ( 0 -128.1)
a
 median b ränge
Gl: fairly managed group
G2: averagely managed group
G3: poorly managed group
c
 n.d.: not determined
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Determination of glycated plasma albumin
Human serum albumin was purified by affinity chromatography
on Affi-gel Blue. A 0.7 ml column was equilibrated with 1.5 ml
0.02 mol/1 Na-phosphate buffer, pH 7.1. Plasma (0.2 ml) was
chromatographed with 1.0 ml of the buffer and then with l .5 ml of
the buffer containing 1.4 mol/1 NaCl. The NaCl fraction was used
for the determination of glycated albumin. The column was regen-
erated with 2 ml 8 mol/1 urea and used again. Glycated albumin
was detected using the thiobarbituric acid procedure of Flücker
& Winterhalter (14) which measures hydroxymethylfurfural re-
leased upon hydrolysis of ketoamine adducts of protein. Protein
was determined by a modified method (16) of Lowry et al. (17).
Data analysis
The unpaired StudenCs t-test was used to compare means of dif-
ferent subpopulations, and the slopes of regression lines were
compared by the Standard statistical method. When the data were
not normally distributed, median, Spearman rs correlation coeffi-
cient and the Mann & Whitney test were used for intergroup com-
parisons (18).
Results
As shown in figure l a, only a weak correlation was
observed between blood glucose levels and urinary
glucose levels. However, some increments were seen
in urinary levels with increased concentrations of
blood glucose levels. The values for glycated haemo-
globins and glycated albumin in normal subjects and
diabetics are shown in table 2. In table 3 the statisti-
cal significance (P values) of the differences in var-
ious parameters are summarized. There were signifi-
cant differences in glycated haemoglobins äs well äs
glycated albumin levels between normal subjects and
diabetics (tabs. 2 and 3), but not in postprandial glu-
cose levels in blood (tabs. l and 3). Comparison of
HbAi levels between the various diäbetic gfoüps re-
vealed a considerable difference, except between G2
and G3. Cörrelations öf postprandial blood glucose
levels with other various parameters are shown in
figures l a—Id. Strong correlations were found be-
tween blood glucose levels and both glycated hae-
moglobin and albumin levels. The proportional iii-
creäse in glycated proteihs was greater than the per-
cent increase in postprandial blood glucose (fig. Id).
Blood glucose levels increased by 40%, while the in-
crements in glycated pröteins were about 100%. No
correlation was found between the urinary glucose
levels and HbAi values, however, some correlations
were observed between changes in urinary glucose
levels and glycated albumin values.
As shown in figures 2a*-2c there were significant
correlations between changes in HbAi levels and
glycated albumin levels. The greater absolute change
was found in glycations of albumin compared with
haemoglobin, i.e,, the HbAi increments were about
57% while glycated albumin increased by 2 units to
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Fig. 1. Correlations between changes in postprandial blood glu-
cose levels and other parameters: A, urinary glucose lev-
els; B, HbAi levels by the column method; C, HbAi levels
by the chemical method; D, glycated albumin levels.
A: y = 10.59 -l- 0.027x, r = 0.214.
B: y = 0.96 + 0.73x, r = 0.72.
C: y = 1.44 + 2.47x, r = 0.85.
D: y = 4.8 + 2.45 , r = 0.662.
·, normal; ·, Gl; A, G2; O, G3.
4 (100%). Comparison of values from the column
method and the chemical method for HbAi showed
an excellent correlation (r = 0.95).
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Discussion
In recent years, in the field of diabetes, interest has
been focused on the glycation of haemoglobin (l—
3), albumin (4-6), lipoprotein (19), and peptides
(20). It has been reported that glycohaemoglobin
provides an index of the patient's average blood glu-
cose concentration over a long-time period, and gly-
coalbumin a relatively short-term period (6—8). The
present data confirm that HbAi äs well äs glycoal-
bumin are well correlated with changes in the blood
glucose concentration (fig. 1). Although postpran-
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Fig. 2. Correlations between changes in glycated proteins.
a: HbAi by the column method vs. HbAi levels by the
chemical method. y = -0.58 + 2.57x, r = 0.95.
b: HbAi levels by the column method vs. glycated albu-
min levels. y = 5.03 + 3.38x, r = 0.843.
c: HbAi levels by the chemical method vs. glycated al-
bumin levels. y = 2.17 + 1.55x, r = 0.783.
O, normal; B, Gl; A, G2; O, G3.
dial blood glucose was investigated it can be seen
that glycoproteins reflect the blood glucose levels.
Goldstein et al. (21) reported that approximately 9—
11% of HbAic could reflect very recent changes in
blood glucose levels. In view of the short half-life of
albumin (2-^3 weeks) we can assumerthat a higher
fraction of glyeoalbiimm reflects recent cfianges in
blood glucose levels. Contrary tp recent reports (22,
23), the amount of glucose in the urine was only
weakly correlated with glycated protein levels. This
may well be due to the short collection period (over
a 24 hour-period) or due to other factors (24). Gab-
bay et al. (25) reported that glucose levels in the
urine collected 2 months prior to the determination
were well correlated with glycohaemoglobin values.
It is, therefore, not surprising to find only a weak
correlation between glycöalbumin levels and the uri-
nary glucose values. However, the most iiiterestmg
observation is that there was very little overlap of
glycoprotein values between the normal and diabetic
groups (fig. 2), in contfast with blood glucose (fig.
1). Furthermore, there was also very little overlap of
the measuremeüts of glycoproteins, especially of gly-
cated albumin, between fairly well controlled and
poorly managed diabetic groups. From these results
we can conclude that the measurements of glycated
proteins are important in diabetes äs more reliable
and stable Integrators than blood glucose or urinary
glucose determinations. Among various methods for
glycohaemoglobin measurement, the chemical meth-
od which measures a stable ketoform of HbAi, offers
an inexpensive rapid procedure. The mini cation co-
lumn method which measures a läilule form of HbAi
äs well, may, on the other hand, be better for deter-
minations which reflects recent changes in blood glu-
cose levels. The glycöalbumin determination in-
volves an affinity chromatography Step for the isola-
tion of plasma albumin. Although we found a very
good correlation between the increments of glycöal-
bumin and glycoprotein levels in plasma, it may be
helpful to determine specifically glycöalbumin, in
view of the reports of albumin deposition in basal
membranes (26) and possible roles of glycated al-
bumin in microangiopathy (23). Furthermore, the
greatest absolute changes in glycöalbumin in com-
parison with those in glycohaemoglobin or plasma
glucose (figs. l and 2) again indicate the measure-
ment of glycöalbumin to be a sensitive index for the
diabetic control.
In conclusion, routine determinations of glycated
protems are valuable for the physicians in diabetic
clinicsonot only for the dietary management of the
patients, but also for a better understanding of the
pathogenesis of disease. v *
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Tab. 2. Glycated haemoglobin (HbAi) measured by cation-exchange column chromatography and by the colorimetric method, and
glycated albumin in diabetic children and normal subjects.
Subject HbAi
(% of total haemoglobin)
HbAi(hydroxymethylfurfural,
nmol/mg haemoglobin)
Glycated albumin
(hydroxymethylfurfural,
nmol/mg protein)
Normal
Diabetics
Gl
G2
G3
Total
15
14
8
21
43
Range
5.9- 7.9
9.6-18.4
12.5-19.2
11.7-21.6
9.6-21.6
Mediän
6.8
14.6
16.7
16.6
15.8
Range
2.00-3.30
3.31-5.70
5.20-7.70
5.10-8.30
3.30-8.30
Mediän
2.94
5.45
5.30
6.10
5.70
Range
0.28-1.35
0.80-4.50
1.50-4.00
1.23-6.80
0.80-6.80
Mediän
1.00
2.00
2.60
2.80
2.20
G l: fairly well managed group
G2: group with average control
G3: poorly managed group
Tab. 3. Statistical significance (Mann & Whitney test) of the differences in various parameters between normal and diabetic groups.
Group
Normal vs. diabetics
Normal vs. Gl
Glvs.G2
Gl vs.G3
G2 vs. G3
Glucose
Blood
P <0.025
n.s.c
n.s.c
P<0.001
n.s.c
Urine
—
n.s.c
P <0.001
P <0.005
HbA,
Column method3
P<0.001
P <0.001
P <0.05
P<0.01
n.s.c
Chemical method6
P<0.001
P <0.001
P<0.01
P<0.01
n.s.c
Glyco-
albumin
P<0.001
P<0.001
P <0.05
P<0.001
n.s.c
a
 cation column Chromatographie method
b
 chemical photometric method
c
 not significant
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